Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,169-9,180 of 10,661

Drug study icon

CompletedNCT00223418

Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 52 Years

Countries: United States
Sponsor: The University of Texas Health Science Center at San Antonio
Condition: Schizophrenia

Behavioral study icon

CompletedNCT01211405

Study Comparing Three Doses of MDMA Along With Therapy in Veterans With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: Resilient Pharmaceuticals
Condition: PTSD

Behavioral study icon

CompletedNCT00108407

Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, AddictionBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: Depression, Addiction

Behavioral study icon

TerminatedNCT04784143

Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: Resilient Pharmaceuticals
Condition: PTSD

Drug study icon

CompletedNCT00134459

Study Evaluating Bifeprunox in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Bipolarity, Depression

Drug study icon

TerminatedNCT00366327

Study Evaluating Bifeprunox in people with Schizophrenia.

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 66 Years

Countries: United States
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Schizophrenia

Drug study icon

CompletedNCT00488618

Study Evaluating Cariprazine (RGH-188) in the Treatment of people with Acute Mania

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Forest Laboratories
Condition: Bipolarity

Drug study icon

TerminatedNCT00827489

Study Evaluating HTC-867 in Healthy Young and Elderly Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Schizophrenia

Drug study icon

CompletedNCT06126497

Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Suven Life Sciences Limited
Condition: Depression

Drug study icon

WithdrawnNCT00892021

Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Schizophrenia

Drug study icon

WithdrawnNCT00781794

Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States, France
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Schizophrenia

Drug study icon

Active Not RecruitingNCT07046494

RAP-219 for Bipolarity

This study is active but not recruiting in the United States. It is testing RAP-219 for Bipolarity.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Rapport Therapeutics Inc.
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.